GSK plc
Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.
To tackle some of the world’s greatest healthcare challenges, we’ve created an inspiring working environment with world-class talent and opportunities. In India, we merge our brightest minds and cutting-edge resources to make a real difference to lives the world over. Search jobs.
Life at AstraZeneca. We’re curious about science and the advancement of knowledge. We find creative ways to approach new challenges. We’re driven to make the right choices and be accountable for our actions. As an organisation centred around what makes us human, we put a big focus on people.
AstraZeneca | 2,924,939 followers on LinkedIn. What science can do | We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the...
Jun 13, 2022 · The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary analysis of data irrespective of interdose interval from trial participants who received 2 standard doses with an interval varying from about 4 to 12 weeks.
Feb 3, 2021 · COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials. 3 February 2021 07:00 GMT. The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca ...
Feb 28, 2023 · PUBLISHED 28 February 2023. AstraZeneca completed the acquisition of Alexion in the year 2021 and is now expanding its portfolio globally to bring innovative therapies for patients living with rare diseases in India. Receives regulatory approval for its molecule ‘Selumetinib’ in India.
Jun 1, 2024 · New Delhi: Granting the local phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca Pharma's Benralizumab solution for Injection 30 mg/ml in auto-injector for the indication of “as an add-on maintenance treatment for severe asthma ...
